N-(1-(ethylthio)-2-(5-((4-(morpholinomethyl)phenylethynyl)-1H-benzo[d][1,2,3]triazol-1-yl)ethyl)-N-hydroxyformamide

ID: ALA4741753

PubChem CID: 162647020

Max Phase: Preclinical

Molecular Formula: C24H27N5O3S

Molecular Weight: 465.58

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCSC(Cn1nnc2cc(C#Cc3ccc(CN4CCOCC4)cc3)ccc21)N(O)C=O

Standard InChI:  InChI=1S/C24H27N5O3S/c1-2-33-24(29(31)18-30)17-28-23-10-9-20(15-22(23)25-26-28)6-3-19-4-7-21(8-5-19)16-27-11-13-32-14-12-27/h4-5,7-10,15,18,24,31H,2,11-14,16-17H2,1H3

Standard InChI Key:  OFHGBRVYJBJAAC-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
   37.2109   -9.5666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2097  -10.3939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9245  -10.8068    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9227   -9.1538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4949  -10.8059    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7748  -11.2125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0564  -11.6180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3489  -11.1944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6309  -11.5993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6225  -12.4251    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3380  -12.8444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0531  -12.4370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9048  -12.8317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1937  -12.4133    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.2004  -11.5883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4935  -11.1701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7732  -11.5731    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.7644  -12.3990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4758  -12.8219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.6381   -9.5630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.6429  -10.3894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.4304  -10.6401    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.9123   -9.9687    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.4226   -9.3030    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   39.6729   -8.5170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.4788   -8.3407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.7292   -7.5546    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   41.5351   -7.3783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.7855   -6.5923    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   40.1735   -6.9447    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   41.0345   -8.9505    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   40.7842   -9.7366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.3397  -10.3465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3 21  1  0
 20  4  1  0
  4  1  2  0
  2  5  1  0
  5  6  3  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
 10 13  1  0
 13 14  1  0
 14 15  1  0
 14 19  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 20  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  2  0
 27 30  1  0
 26 31  1  0
 31 32  1  0
 32 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4741753

    ---

Associated Targets(non-human)

lpxC UDP-3-O-acyl-GlcNAc deacetylase (700 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 465.58Molecular Weight (Monoisotopic): 465.1835AlogP: 2.59#Rotatable Bonds: 8
Polar Surface Area: 83.72Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 7.88CX Basic pKa: 6.73CX LogP: 3.22CX LogD: 3.26
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.18Np Likeness Score: -1.50

References

1. Furuya T,Shapiro AB,Comita-Prevoir J,Kuenstner EJ,Zhang J,Ribe SD,Chen A,Hines D,Moussa SH,Carter NM,Sylvester MA,Romero JAC,Vega CV,Sacco MD,Chen Y,O'Donnell JP,Durand-Reville TF,Miller AA,Tommasi RA.  (2020)  N-Hydroxyformamide LpxC inhibitors, their in vivo efficacy in a mouse Escherichia coli infection model, and their safety in a rat hemodynamic assay.,  28  (24): [PMID:33160146] [10.1016/j.bmc.2020.115826]

Source